SmartTRAK Life Sciences News and Analysis Blog

2 min read

What's New in Wound Care Reimbursement 2022: An Interview w/ Kathleen Schaum

3/4/22 11:36 AM

Shaum Interview Header-1Kathleen “Kathy” Schaum, President of Kathleen D. Schaum & Associates, discusses her thoughts on the impact of COVID-19 on wound care and reimbursement.

Kathy is a “go-to” provider of wound care reimbursement information, education and strategy to manufacturers and providers. In this interview with SmartTRAK, Kathy shares her thoughts on the impact of COVID-19 on the delivery and reimbursement of wound care and the advancements in remote monitoring, diagnostics and sensors. To find out more, including Kathy’s take on skin substitute/CTP trends, click on the following video recorded live via Google Meet (25:13 min). Specific interview topics by time code are outlined below. A link to the complete transcript of the interview is also provided below.

Download the Kathleen Schaum Interview Transcript
Interview Topics by Timecode:

06:00 Hear Kathy’s thoughts on how COVID-19 and the public health emergency changed wound care.

09:00 Learn more about the evolution of remote monitoring in wound care.

11:00 Listen to Kathy’s thoughts on the importance of diagnostic devices in wound care.

12:00 Find out about skin substitute / CTP trends and reimbursement realities.

19:00 The movement of wound care to the home, increases in Medicare Advantage members and the development of sensors in wound care.

21:00 Understand the importance of having a parallel FDA and CMS strategy when developing a new product or procedure.

To download a complete transcript of the "Wound Care Reimbursement: What's New in 2022" interview with Kathleen Schaum, just click the button below.

Download the Transcript


SmartTRAK now offers Skin Substitutes (CTP) Site of Care. This module will make you an expert in Site of Care information for the Skin Substitutes market. Receive market shares, 5-Year Growth Projections and Company & Product Performance across multiple sites of care. Download our PDF to get a preview of what's available!

Gary Delhougne
Written by Gary Delhougne

SmartTRAK GM, Wound. Licensed attorney with 20 years’ medical device and consulting experience in market access, health economics and policy roles at Smith & Nephew, Covidien, Avalere Health and Ernst & Young.

    Follow Us on Social Media

    Recent Articles